Do Patients With IBD Continue Using Pain Medication After Starting Advanced Therapy?
Researchers examined pain medication usage trends before and after initiating advanced therapy in patients newly diagnosed with inflammatory bowel disease.
Researchers examined pain medication usage trends before and after initiating advanced therapy in patients newly diagnosed with inflammatory bowel disease.
Adam S. Faye, MD, discusses his team’s research on how antibiotics increase the risk for inflammatory bowel disease among older adults and what clinicians should keep in mind.
Researchers assessed whether rheumatoid arthritis is causally related to inflammatory bowel disease and vice versa.
Researchers examined changes in fecal metabolites resulting from either the Crohn disease exclusion diet plus enteral nutrition or the exclusive enteral nutrition diet and the association with remission.
The application is supported by data from the two phase 3 induction studies, U-EXCEED and U-EXCEL, and one phase 3 maintenance study, U-ENDURE.
The application is under review for relapsing forms of multiple sclerosis and Crohn disease.
The sBLA is supported by data from a phase 1 pharmacokinetics bridging study comparing Hyrimoz 50mg/mL and citrate-free Hyrimoz HCF.
The approval was based on data from two phase 3 induction studies, and one phase 3 maintenance study.
Researchers evaluated the effects of psychological health on prognosis for inflammatory bowel disease.
Researchers evaluated the effects of antibiotic exposure, specifically cumulative use, timing of use, and the association with older-onset IBD.